VEGFA and breast cancer: Furthermore, the aim of the present study was to evaluate the concentrations of VEGF and CA 15-3 in the plasma of patients with low-stage BC, as well as in control groups, i.e., subjects with benign breast lesions (fibroadenoma), and healthy individuals.